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Abstract Furin, a member of the subtilisin-like pro-protein
convertase family, is a type I membrane protein that under-
goes ectodomain shedding. Metabolic labeling of cells stably
expressing furin demonstrated that the shed form of furin is
detected after 30 min. Moreover, sequence analysis revealed
that speci¢c residues of the cysteine-rich region of furin aligned
with those of tumor necrosis factor receptor, which is also shed.
Introduction within furin’s cysteine-rich region of mutations that
impair TNFR1 shedding also abolished furin shedding. Our re-
sults show that shedding of furin occurs rapidly and further
suggest that speci¢c cysteine residues may impart a conforma-
tion to the enzyme, thereby a¡ecting its susceptibility to
proteolysis. + 2002 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Mammalian subtilisin-like pro-protein convertases (SPCs)
are calcium-dependent serine proteases involved in the endo-
proteolytic cleavage of precursor proteins to yield biologically
active polypeptides [1]. The SPC family consists of seven dis-
tinct members (SPC1^SPC7) that vary in their tissue and sub-
cellular distribution and in their enzymatic and biochemical
properties. Numerous studies on one of these enzymes, SPC1/
furin, have greatly contributed to our understanding of cellu-
lar and molecular processes such as enzymatic function, pro-
tein tra⁄cking as well as viral and bacterial pathogenesis [2,3].
Furin is a mosaic protein consisting of a series of multi-
functional domains. At its N-terminus portion, a signal pep-
tide directs the translocation of the growing peptide chain to
the endoplasmic reticulum and the secretory pathway [4].
Next, the pro-region initially folds onto the native protein,
thereby keeping the enzyme in a zymogen or inactive state.
The pro-region is cleaved early in the endoplasmic reticulum
by an intramolecular autocatalytic process [5], then associates
with the catalytic domain where it guides the protein through
the endoplasmic reticulum (ER) and the Golgi apparatus for
its eventual enzymatic activation [6]. The catalytic region that
follows possesses the characteristic catalytic triad (Asp, His,
Ser) found in the subtilisin family of serine proteases. C-ter-
minal to the catalytic domain is the P domain that has been
found to be essential for the enzymatic activity [7]. The cys-
teine-rich region (CRR) has no known role and is followed by
a trans-membrane region that anchors the enzyme in the
membrane of the TGN or the cell surface. Finally, the cyto-
solic tail contains the information necessary for furin’s sorting
to various intracellular compartments [3,4,8].
It has been demonstrated that furin can process an exten-
sive range of precursor proteins in the TGN/biosynthetic
pathway but also in the endocytic pathway, at the cell surface
and possibly within the extracellular matrix following shed-
ding. Apart from numerous studies describing the processing
of bacterial precursor molecules by cell surface or shed SPC1,
proteins such as pro¢brillin, a large extracellular matrix gly-
coprotein, have been shown to be potential extracellular sub-
strates for furin [9], although it remains to be determined
whether proteolytic cleavage is performed by the membrane
anchored or the shed form of the enzyme. Recently, it has
been proposed that the TGF-L1 and TGF-L2 precursors,
known to be processed by furin in the TGN [10,11], may
also be cleaved extracellularly by a secreted or shed form of
the enzyme [12].
Ectodomain shedding is a cellular process whereby the
extracellular domains of trans-membrane proteins are proteo-
lytically cleaved, often at the cell surface [13]. This post-trans-
lational modi¢cation is known to modulate biological func-
tion by releasing such proteins as growth factors, enzymes and
receptors. For example, tumor necrosis factor receptor type 1
(TNFR1) will normally undergo shedding in order to release a
soluble moiety able to bind TNFK. This will reduce the cell’s
sensitivity to TNFK [14], thus regulating the in£ammatory
process. Although some shedding proteases, such as tumor
necrosis K-converting enzyme (TACE/ADAM17) [15], have
been characterized, there are evidences stemming from the
use of TACE knockout mice that suggest the existence of
non-TACE shedding mechanisms [16].
Although many studies have reported shedding of furin,
few have thoroughly characterized this process. Here we dem-
onstrate that furin shedding occurs intracellularly and may
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depend on the integrity of the conformation of the enzyme’s
CRR. These results add to our understanding of the molec-
ular determinants involved in targeting furin to various cellu-
lar locations.
2. Materials and methods
2.1. Cell culture, transfection and clonal cell line isolation
QBI-293A cells (293A, Quantum Biotechnologies, Montreal, QC,
Canada), derived from the HEK293 cell line, were grown in complete
DMEM containing 10% heat-inactivated FBS, 2 mM L-glutamine, 50
U/ml penicillin and 50 Wg/ml streptomycin. Sub-con£uent 293A cells
were transfected with 2 Wl of Fugene6 reagent (Roche Diagnostics,
Laval, QC, Canada) per Wg of DNA 24 h prior to each experiment.
FLAG-tagged furin expressing stable cell line was obtained from a
population of 293A cells that was selected for 3 weeks with G418 (0.8
mg/ml, Life Technologies, Burlington, ON, Canada) using the cloning
ring method. Cells were screened by immunoblot with anti-furin and
monoclonal M1 antibodies. The cell line termed C4-293A corresponds
to a stable non-clonal population of cells.
2.2. Recombinant DNA constructs
FLAG-tagged furin was constructed by site-directed mutagenesis
using the Transformer mutagenesis kit (Invitrogen, San Diego, CA,
USA) and an oligonucleotide (5P-GCTCCTGGTACACGTCCTTGT-
CATCGTCGTCCTTGTAGTCCCGTTTAGTCCGTCGC) to insert
the FLAG epitope (AspTysLysAspAspAspAspAla) after Arg107 be-
tween the pro-region and the catalytic domain. The cDNA encoding
furin (without the FLAG epitope) was sub-cloned as an EcoRI^
EcoRV fragment into EcoRI^SmaI of pCI^Neo. An ApaI^NotI frag-
ment was used to replace a similar insert in pCI^Neo/hSPC1 to yield
the corresponding FLAG constructs. Single mutations in the CRR of
furin were obtained by site-directed mutagenesis as above using the
following oligonucleotides: C610R (5P-CCAGAAGAGCCGTGTC-
CAGCAC, mutated codon is underlined), C614Y (5P-GTCCAGCAC-
TACCCTCCAGGC), S639M (5P-CATCCGGGCCATGGTGTGCG-
CC), C641F (5P-GCCAGCGTGTTCGCCCCCTG), and C675R (5P-
GGAGCAGACGCGTTCCCGGC).
2.3. Metabolic labeling and shedding quanti¢cation (shedding assay)
Metabolic labeling experiments were performed 24 h post-transfec-
tion or when cells reach 90% con£uence. Cells were washed twice with
warm PBS and incubated in Met/Cys-free medium (MEM Select-
Amine kit, Life Technologies) supplemented with 10% dialyzed
FCS, 1 mM L-glutamine, and 50^100 WCi of Expre35S35S (NEN
Life Science Products, Boston, MA, USA) for the indicated period
of time. Chase was done in complete medium. Cell layer was washed
twice with PBS and cells were lyzed with 1 ml of radioimmunopreci-
pitation assay (RIPA) bu¡er (50 mM Tris pH 7.5, 100 mM NaCl,
1 mM CaCl2, 1% NP-40, 0.5% deoxycholic acid and 0.1% SDS) con-
taining protease inhibitors (1 WM aprotinin, 10 WM pepstatin, 10 WM
leupeptin and 0.5 mg/ml pefabloc SC). Samples were centrifuged at
15 000Ug for 10 min to remove insoluble material. M1 (10 Wg/ml,
Sigma) antibody was added and incubated overnight at 4‡C. Protein
A/G Plus-agarose (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
beads were added and incubated for 1 h at 4‡C. Beads were washed
three times with 1 ml of RIPA bu¡er and labeled proteins were re-
solved by SDS^PAGE. Gels were treated with ENTENSIFY reagent
(NEN Life Science), dried and exposed for £uorography. For shed-
ding quanti¢cation, gel bands were excised and mixed with liquid
scintillation cocktail to determine the amount of radioactivity of
each band. A gel slice of similar dimension excised from control
sample was used as background value and subtracted to yield speci¢c
radioactivity of each sample. BFA (5 uM) and monensin (5 uM) were
added to the labeling mixture where indicated.
2.4. Furin enzymatic assays
Proteins secreted from transfected cells were accumulated in Dul-
becco modi¢ed Eagle medium (DMEM)-based serum-free medi-
um and 0.1 ml was used in a £uorogenic assay using 100 WM
t-BocRVRR-Amc as substrate in assay bu¡er [200 mM N-(2-hydroxy-
ethyl)piperazine-NP-(2-ethanesulfonic acid) (HEPES), 1 mM CaCl2,
1 mM L-mercaptoethanol] at 37‡C. Hydrolyzed 7-amido-4-methylcou-
marin (Amc) was measured at EXV =380 nm and EXV =460 nm.
2.5. Homology modeling
All the molecular modeling was performed using the INSIGHTII
(2000) suite of programs (Molecular Simulations) on a Silicon
Graphics Octane2 workstation. Sequence alignment and coordinate
transfer was performed with the HOMOLOGY module. 8 angle tor-
sion and mutations C614Y/C641F were performed using the BIO-
POLYMER module and the potential energy of resulting model
was minimized using DISCOVER with the CVFF force ¢eld.
3. Results
3.1. Characterization of the shedding process
To examine the kinetics of furin shedding, we metabolically
labeled proteins of C4-293A cells stably expressing a FLAG-
tagged furin followed by immunoprecipitations using the M1
Fig. 1. Kinetics of furin ectodomain shedding. A: Accumulation of
shed furin in culture medium and depletion of cellular furin. 35-mm
plates of C4-293A cells were pulse-labeled with [35S]Met/Cys for a
period of 30 min and chased in complete medium for the indicated
period of time (0^4.5 h). Labeled proteins from cell extracts pre-
pared in RIPA bu¡er or cultured medium were immunoprecipitated
with M1 antibody. The amount of radioactivity immunoprecipitated
was quanti¢ed by liquid scintillation counting and plotted as a func-
tion of chase time. Radioactivity corresponding to the shed furin
(a), cellular furin (b) and total (F) from cells and media are pre-
sented in cpm. The initial increase in cellular furin is due to process-
ing of the zymogen that is not detected by the M1 antibody. Analy-
sis by measurement of the total amount of immunoprecipitated
furin (in cpm) revealed that only 5% of total radioactivity was lost
during the 4.5-h chase period. B: Time course of furin shedding.
Clonal cells expressing FLAG-tagged furin were pulse-labeled with
500 WCi of [35S]Met/Cys in a 90-mm petri dish and chased in radio-
active-free medium. Medium was harvested initially at every 10 min,
then every 30 min and replaced with fresh medium every time over
a 6 h period. Final cell extract was prepared in RIPA bu¡er, sam-
ples were immunoprecipitated with M1 antibody and quanti¢ed as
in A. * indicates the mature membrane-bound form of furin.
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antibody, which only detects the mature form of the enzyme.
Figure 1Ashows the characteristic furin doublet (100 and 106
kDa) in cells representing processed enzyme along with an 81-
kDa form. This entity is the shed form of the enzyme also
detected in the media. The kinetics of shedding was then ex-
amined. Following the pulse period (30 min), we either accu-
mulated secreted proteins over a 0.5 to 4.5-h chase period (35-
mm plates, Fig. 1A) or replaced the medium initially at 10-
min intervals, then at 30 min intervals (90-mm plates, Fig.
1B). The 81-kDa shed form was detected intracellularly after
the 30-min pulse (Fig. 1A, lane P), peaking between 1^1.5 h
and accumulating intact in the media over the next 3 h. In-
deed, during the 4.5-h period no other forms of furin were
detected with the M1 antibody, suggesting that it was not
processed into smaller forms. Over this time period, we deter-
mined that shedding is the major pathway by which mem-
brane-bound furin is post-translationally modi¢ed since less
than 5% of total furin immunoreactivity is lost through other
processes (see plot Fig. 1A). Importantly, time-course studies
showed that we detected soluble furin in the media after only
a 10-min chase (Fig. 1B) with a maximal secretion rate ob-
served between 1h and 2h.
To establish where furin shedding takes place, we treated
the C4-293A cell line with the Golgi-disturbing agents Brefel-
din A (BFA) and monensin (Fig. 2). Pulse-labeling analysis
revealed that BFA, which inhibits protein transport between
the ER and the Golgi apparatus, does not impede production
of the mature form of the enzyme (detection with M1) but
a¡ects the glycosylated/sialylated state of the enzyme as dem-
onstrated by the absence of the 106-kDa form in cells. More-
over, production of shed furin was completely abolished (cell
and media), whereas treatment with monensin, which inhibits
post-Golgi transport, only a¡ected secretion of the shed form
and not its production. Taken together, these results clearly
identify the Golgi network as the major site of furin shedding.
3.2. Furin cysteine residues of the CRR align with those of
TNFR1
Using the BLAST search engine, we searched the GenBank
for proteins having homologous regions to the CRR of furin
(residues 596^675). Fig. 3 depicts the alignment of the CRR of
furin with the CRR of tumor necrosis factor receptor (TNFR)
family members TNFR1 and TNFR2. We also found patterns
of sequence similarity with the CRRs of insulin-like growth
factor receptor and the erbB receptor protein-tyrosine kinase
(not shown). The crystallographic structure of the extracellu-
lar domain of TNFR1 [17] has enabled the assignment of
those cysteine residues participating in disul¢de bridges.
Although the overall similarity of sequence is low within
this region, it can be seen that of the six pairs of cysteine
residues forming disul¢de bridges in the 89-residue CRR of
furin, four pairs are ‘conserved’ within TNFR1 and TNFR2.
Based on the alignment of the CRR of furin with TNFR1,
Cys641 (which could correspond to C80 of TNFR1) may es-
tablish a disul¢de bond with Cys614. Following reports of
mutations within this region [18] that a¡ect shedding, we in-
troduced those mutations at those conserved positions in the
CRR of furin to ascertain the role of those residues in the
shedding process.
3.3. Impaired shedding of furin with the C614F and C641F
mutations
Five furin mutants corresponding to the TNFR1 naturally
occurring mutants [18] were constructed (C610R, C614Y,
S639M, C641F, C675R). These proteins and wild-type,
Fig. 2. Furin is rapidly shed in the secretory pathway. Cells were
treated as in Fig. 1B in the presence of 5 WM BFA or 5 WM mo-
nensin, except that cells were pulsed for only 3 h. sfurin, shed furin.
Fig. 3. Sequence alignment of the CRR of human furin with TNF receptors. Sequences from furin (residues 587^675), TNF-RI (residues 44^
125) and TNR-RII (residues 18^97) were aligned using hierarchical clustering [35]. Identical amino acids are shadowed and semi-conserved or
amino acids of similar properties are grayed. Disul¢de bridges found in TNF-Rs, as determined by the crystallographic structures, are drawn
below the alignment. Arrows indicate the ¢ve point mutations in TNF-RI related to the autosomal periodic fever syndrome identi¢ed by
McDermott and colleagues [18].
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£agged furin were transiently expressed in 293A cells, which
were then metabolically labeled with [35S]Met/Cys for 3 h and
harvested immediately. Fig. 4A shows that immunoprecipita-
tion of cell lysates with the M1 antibody led to the detection
of the characteristic doublet at 106 kDa and 100 kDa, corre-
sponding to the two glycosylated/sialylated states of the ma-
ture form of the enzyme. This indicated that mutations within
the CRR of furin did not a¡ect its capacity for autocatalytic
activation. Immunoprecipitation of the culture media enabled
us to detect the shed form of the enzyme. This form appeared
in the media of cells transfected with the C610R, S639M and
C675R mutants at levels that were similar to those found in
the media of cells expressing the wild-type enzyme. However,
only a weak signal was detected in the media of cells trans-
fected with the C614Y and C641F constructs. Based on the
alignment with the TNF receptors, these two cysteine residues
could potentially form a disul¢de bridge. The diminished sig-
nal revealed by immunoprecipitation was con¢rmed by mea-
suring the enzymatic activity in the media of transfected cells
(Fig. 4B). Indeed, media originating from the C614Y and
C641F mutant expressing cells exhibited a marked reduction
in their capacity to cleave a furin £uorogenic substrate. To-
gether, these results suggest that speci¢c cysteine residues
within the CRR are possibly involved in imparting a confor-
mation to this region of the molecule, enabling the eventual
recognition and cleavage by the sheddase.
4. Discussion
We and others had previously demonstrated the capacity of
furin to undergo proteolytic shedding resulting in a soluble,
secreted protein of 81 kDa [19^22]. Here, we demonstrate that
this process may occur in the Golgi network. Detection of the
81-kDa form intracellularly occurs after 30 min and is also
found early in the media. Considering that cleavage of the
pro-region of furin has been found to occur within a t1/2 of
10 min in the ER and is necessary for export [23], this would
imply that the shedding process may take place in the Golgi
apparatus. This is con¢rmed with our results using brefeldin
A. Moreover, this is also supported by treatment with mo-
nensin, a known inhibitor of post-Golgi transport, which en-
ables shedding but not secretion of the soluble form. How-
ever, we cannot exclude the possibility that (1) the use of BFA
could indirectly a¡ect the activation of the sheddase in the
Golgi, thereby leading to lack of shedding or (2) that cell-
surface furin may also be shed perhaps by family of proteases
other than those found in the Golgi. Because dissociation of
the pro-region from membrane-bound furin has a t1/2 of 105
min, it is conceivable that the shed form reaches the late
secretory pathway at a faster rate, thereby resulting in its
e⁄cient secretion. Interestingly, the present ¢ndings resemble
those recently obtained for another mammalian subtilase,
SKI-1, whereby it was shown that shedding would occur fol-
lowing exit from the ER [36].
To date, ¢ve distinct metalloproteases have been shown to
be involved in shedding membrane proteins (TACE/
ADAM17, kuzbanian/ADAM10, ADAM9, ADAM19 and
MMP-7) and most, if not all, perform the shedding process
at the cell surface. Mutations at or near the cleavage site of
various proteins have led to the conclusion that the critical
parameter for shedding of speci¢c proteins by a given metal-
loproteases is a relaxed sequence speci¢city of the enzyme
along with the conformation and/or length of the stalk region
rather than conservation of the amino acid sequence [24].
However, a recent report describing shedding of the angioten-
sin-converting enzyme (ACE), has demonstrated that another
interpretation of the shedding process could be that an en-
zyme of the serine protease family could be implicated as a
sheddase and that this event would occur in the ER [25].
Other reports have shown how this stalk region is sensitive
to mutations yielding increased levels of shed ACE [26].
Although the enzyme responsible for furin shedding has not
yet been identi¢ed the site at which cleavage occurs is Arg683
([27] and unpublished data), reminiscent of an ACE or ACE-
like sheddase. Indeed, it has been shown that the site of cleav-
age of ACE by its secretase is Arg1203, 27 residues on the
extracellular side of its trans-membrane domain, similar to
Arg683 of furin, which is shed 32 amino acids from the mem-
brane. Clearly, additional experiments will be needed to iden-
tify the SPC1 sheddase.
We hypothesized that the CRR of SPC1 could play a role
in shedding following reports that germline mutations in the
extracellular domain of TNFR1 (more speci¢cally within its
CRR) de¢ned a family of dominantly inherited autoin£amma-
Fig. 4. Analysis of point mutations in the CRR of furin and the ef-
fect on shedding. A: Mutations in the CRR of furin impair shed-
ding. 293A cells were transiently transfected with an empty plasmid
(Ctrl), wild-type FLAG-tagged furin (WT) or the various mutant
cDNAs. Cells were pulse-labeled with [35S]Met/Cys for 3 h, media
was harvested and cell extracts were prepared in RIPA bu¡er fol-
lowed by immunoprecipitation with M1 antibody. The arrows indi-
cate the shed form whereas the asterisk indicates the mature mem-
brane-bound forms of furin. B: Measurement of enzymatic activity
of shed furin. 293A cells were transfected as in A with the various
cDNAs. Proteins were accumulated in serum-free medium for 30 h
and assayed as described in Materials and Methods. Each assay was
normalized with a pulse-labeling experiment following media remov-
al. Media was harvested and cell extracts were prepared in RIPA
bu¡er, immunoprecipitated with M1 antibody, and radioactive
bands were counted for radioactivity content by liquid scintillation
counting. For each assay, background enzymatic activity from con-
trol cells was subtracted from all obtained values and normalized
with furin expression level as determined by the labeling experiment
of each sample. Data are compared to wild-type samples.
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tory disorders [18]. More speci¢cally, of the six di¡erent mu-
tations of TNFR1 found in the a¡ected families, ¢ve dis-
rupted conserved extracellular disul¢de bonds (illustrated in
Fig. 3). It had been proposed that such substitutions would
signi¢cantly alter the structure and, hence, the biosynthesis/
shedding of TNFR1. One particular mutation, C80F, led to a
signi¢cant increase in the levels of membrane TNFR1 and
reduced clearance, suggesting the role of this region of the
receptor in conferring a proper conformation and enabling
the eventual cleavage of the ectodomain.
Our results suggest that furin carries structural information
within its CRR that facilitates shedding of its ectodomain.
Interestingly, another shed convertase, PC6B, also contains
an extensive CRR while PC7, which is a type I membrane
convertase, is not shed and does not contain a CRR [28,29].
The CRR could participate in the shedding process by impart-
ing a conformation to furin facilitating recognition and cleav-
age by its sheddase. Mutating those cysteine residues (Cys614
and Cys641) that potentially form a disul¢de bridge could lead
to a disruption of the integrity of the CRR, leading to dis-
placement of the main chain toward Arg683 (Fig. 5). The re-
sulting steric hindrance would reduce the accessibility to the
sheddase and drastically a¡ect cleavage at this site.
CRRs exist in a variety of proteins, many of which are
found at the cell surface. Although the role of these domains
has remained rather elusive, some ¢ndings have revealed how
CRRs could be considered either as functional regions in-
volved in cell adhesion [30], in interacting with speci¢c target
proteins [31,32] or in in£uencing conformation enabling di-
merization or shedding of membrane proteins [33].
There have been very few reports describing secreted forms
of endogenous furin in cultured cells. In epidermis, furin was
detected as two molecular weight forms, one without the
trans-membrane domain, suggesting occurrence of post-trans-
lational cleavage to produce a soluble enzyme [34]. Moreover,
glioma cells that produce TGF-L have been shown to release
furin into media as a 98-kDa band [12]. These ¢ndings suggest
that an extracellular form of furin could be directly involved
in processing precursor proteins such as pro-TGF-L, pro-¢-
brillin and pro-¢llagrin. It is still unclear, whether the proteo-
lytic processing of these proteins is the result of the mem-
brane-anchored form of furin or its shed entity. Use of
‘unsheddable’ mutants of SPC1, such as those described
here, could aid in delineating the role of the cleaved, soluble
form of this convertase.
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